Body composition reflects nutritional intakes, losses and needs over time. Undernutrition, ie
fat-free mass (FFM) loss, is associated with decreased survival, worse clinical outcome and
quality of life, as well as increased therapy toxicity in cancer patients. In numerous clinical
situations, such as sarcopenic obesity and chronic diseases, the measurement of body
composition with available methods, such as dual-X ray absorptiometry, computerized
tomography and bioelectrical impedance analysis, quantifies the loss of FFM, whereas body …